| Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review Z Chegini, A Khoshbayan, M Taati Moghadam, I Farahani, P Jazireian, ... Annals of clinical microbiology and antimicrobials 19, 1-17, 2020 | 200 | 2020 |
| The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci … A Shariati, M Dadashi, Z Chegini, A van Belkum, M Mirzaii, ... Antimicrobial Resistance & Infection Control 9, 1-20, 2020 | 140 | 2020 |
| Bacteriophages, a new therapeutic solution for inhibiting multidrug-resistant bacteria causing wound infection: lesson from animal models and clinical trials M Taati Moghadam, A Khoshbayan, Z Chegini, I Farahani, A Shariati Drug design, development and therapy, 1867-1883, 2020 | 92 | 2020 |
| Bacteriophage therapy for inhibition of multi drug‐resistant uropathogenic bacteria: a narrative review Z Chegini, A Khoshbayan, S Vesal, A Moradabadi, A Hashemi, A Shariati Annals of Clinical Microbiology and Antimicrobials 20, 1-13, 2021 | 67 | 2021 |
| An overview of the management of the most important invasive fungal infections in patients with blood malignancies A Shariati, A Moradabadi, Z Chegini, A Khoshbayan, M Didehdar Infection and drug resistance, 2329-2354, 2020 | 54 | 2020 |
| Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: a systematic review of case reports and case series Z Chegini, M Didehdar, A Khoshbayan, S Rajaeih, M Salehi, A Shariati Mycoses 63 (12), 1264-1282, 2020 | 41 | 2020 |
| Graphene-based materials for inhibition of wound infection and accelerating wound healing A Shariati, SM Hosseini, Z Chegini, A Seifalian, MR Arabestani Biomedicine & Pharmacotherapy 158, 114184, 2023 | 38 | 2023 |
| Eugenol: A novel therapeutic agent for the inhibition of Candida species infection M Didehdar, Z Chegini, A Shariati Frontiers in Pharmacology 13, 872127, 2022 | 26 | 2022 |
| Natural Compounds: A Hopeful Promise as an Antibiofilm Agent Against Candida Species A Shariati, M Didehdar, S Razavi, M Heidary, F Soroush, Z Chegini Frontiers in Pharmacology 13, 917787, 2022 | 25 | 2022 |
| PLGA-based nanoplatforms in drug delivery for inhibition and destruction of microbial biofilm A Shariati, Z Chegini, E Ghaznavi-Rad, EN Zare, SM Hosseini Frontiers in Cellular and Infection Microbiology 12, 926363, 2022 | 21 | 2022 |
| An overview of possible pathogenesis mechanisms of Alternaria alternata in chronic rhinosinusitis and nasal polyposis M Didehdar, A Khoshbayan, S Vesal, D Darban-Sarokhalil, S Razavi, ... Microbial Pathogenesis 155, 104905, 2021 | 20 | 2021 |
| The association of Chlamydia pneumoniae infection with atherosclerosis: review and update of in vitro and animal studies A Khoshbayan, F Taheri, MT Moghadam, Z Chegini, A Shariati Microbial pathogenesis 154, 104803, 2021 | 20 | 2021 |
| Helicobacter pylori biofilm and new strategies to combat it MT Moghadam, Z Chegini, A Khoshbayan, I Farahani, A Shariati Current Molecular Medicine 21 (7), 549-561, 2021 | 19 | 2021 |
| The role of Staphylococcus aureus enterotoxin B in chronic rhinosinusitis with nasal polyposis Z Chegini, M Didehdar, A Khoshbayan, J Karami, M Yousefimashouf, ... Cell Communication and Signaling 20 (1), 29, 2022 | 18 | 2022 |
| Three-decade failure to the eradication of refractory Helicobacter pylori infection and recent efforts to eradicate the infection MT Moghadam, Z Chegini, A Norouzi, AS Dousari, A Shariati Current pharmaceutical biotechnology 22 (7), 945-959, 2021 | 18 | 2021 |
| Cinnamomum: The New Therapeutic Agents for Inhibition of Bacterial and Fungal Biofilm-Associated Infection M Didehdar, Z Chegini, SP Tabaeian, S Razavi, A Shariati Frontiers in Cellular and Infection Microbiology 12, 930624, 2022 | 15 | 2022 |
| Gastrointestinal mucormycosis: a periodic systematic review of case reports from 2015 to 2021 M Didehdar, A Moradabadi, AA Anoushirvani, SP Tabaeian, ... Microbial Pathogenesis 163, 105388, 2022 | 15 | 2022 |
| A systematic review of case reports of hepatic actinomycosis Z Chegini, M Didehdar, SP Tabaeian, A Khoshbayan, A Shariati Orphanet Journal of Rare Diseases 16, 1-13, 2021 | 14 | 2021 |
| Novel strategies for inhibition of bacterial biofilm in chronic rhinosinusitis A Shariati, S Vesal, A Khoshbayan, P Goudarzi, D Darban‐Sarokhalil, ... Journal of Applied Microbiology 132 (4), 2531-2546, 2022 | 9 | 2022 |
| The destruction of mucosal barriers, epithelial remodeling, and impaired mucociliary clearance: possible pathogenic mechanisms of Pseudomonas aeruginosa and Staphylococcus … Z Chegini, M Noei, J Hemmati, MR Arabestani, A Shariati Cell Communication and Signaling 21 (1), 306, 2023 | 7 | 2023 |
Aref ShariatiDepartment of medical laboratory sciences, Khomein University of Medical Sciences, Khomein, Iran.在 sbmu.ac.ir 的电子邮件经过验证
